ADV36 adipogenic adenovirus in human liver disease

World Journal of Gastroenterology

Volumn 20, Issue 40, 2014, Pages 14706-14716

  Trovato, Francesca M ^a   Catalano, Daniela ^a   Garozzo, Adriana ^a   Martines, G Fabio ^a   Pirri, Clara ^a   Trovato, Guglielmo M ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Human adenovirus 36; Insulin resistance; Mediterranean diet; Non alcoholic fatty liver disease; Obesity; Ultrasound

Indexed keywords

ADENOVIRUS; ADENOVIRUS ADV36; ADENOVIRUS ADV37; ADENOVIRUS INFECTION; ADIPOSE TISSUE; ADV36 INFECTION; BODY WEIGHT; DISEASE SEVERITY; ECHOGRAPHY; FATTY LIVER; GLUCOSE TRANSPORT; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE MODIFICATION; LIPOGENESIS; LIVER BIOPSY; LIVER DISEASE; LIVER INJURY; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; OBESITY; PHYSICAL ACTIVITY; PROADIPOCYTE; REVIEW; RISK FACTOR; SKELETAL MUSCLE; UPREGULATION; VIRUS REPLICATION; WEIGHT REDUCTION; ADENOVIRUS INFECTIONS, HUMAN; ADIPOGENESIS; ANIMAL; BLOOD; HUMAN ADENOVIRUS C; LIVER; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOGENICITY; PATHOLOGY; TREATMENT OUTCOME; VIROLOGY;

BIOLOGICAL MARKER;

ADENOVIRUS INFECTIONS, HUMAN; ADENOVIRUSES, HUMAN; ADIPOGENESIS; ANIMALS; BIOMARKERS; HUMANS; INSULIN RESISTANCE; LIVER; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; RISK FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84910631086     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i40.14706     Document Type: Review

References (61)

1. Roden M. Mechanisms of Disease: hepatic steatosis in type 2 diabetes - pathogenesis and clinical relevance. Nat Clin Pract Endocrinol Metab 2006; 2: 335-348 [PMID: 16932311]
2. Petersen KF, Dufour S, Feng J, Befroy D, Dziura J, Dalla Man C, Cobelli C, Shulman GI. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men. Proc Natl Acad Sci USA 2006; 103: 18273-18277 [PMID: 17114290]
3. Younossi ZM, Stepanova M, Negro F, Hallaji S, Younossi Y, Lam B, Srishord M. Nonalcoholic fatty liver disease in lean individuals in the United States. Medicine (Baltimore) 2012; 91: 319-327 [PMID: 23117851 DOI: 10.1097/MD.0b013e3182779d49]
4. Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, Shulman GI. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 2005; 54: 603-608 [PMID: 15734833]
5. Yeh MM, Brunt EM. Pathology of nonalcoholic fatty liver disease. Am J Clin Pathol 2007; 128: 837-847 [PMID: 17951208]
6. Lim YS, Kim WR. The global impact of hepatic fibrosis and end-stage liver disease. Clin Liver Dis 2008; 12: 733-46, vii [PMID: 18984463 DOI: 10.1016/j.cld.2008.07.007]
7. Trovato GM, Martines GF, Catalano D. Mediterranean Diet adherence is decreasing in healthy subjects over the years 1996-2010 also in Mediterranean area. FASEB J 2012; 26: 1004
8. Trovato GM, Alonzo E, Cacciola S, Cannizzaro V, La Carrubba R, Pisana P, Purrello A, Raiti ME, Fardella M. The Spontaneous Plants' Recipes Project for enhancing Mediterranean Diet profile change: A sustainable strategy for obesity prevention in childhood, and for contributing to biodiversity maintenance. An intervention of the Italian Food and Nutrition Public Provincial Service. FASEB J 2013; 27: 617
9. Younossi ZM, Baranova A, Ziegler K, Del Giacco L, Schlauch K, Born TL, Elariny H, Gorreta F, VanMeter A, Younoszai A, Ong JP, Goodman Z, Chandhoke V. A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease. Hepatology 2005; 42: 665-674 [PMID: 16116632]
10. Bell LN, Theodorakis JL, Vuppalanchi R, Saxena R, Bemis KG, Wang M, Chalasani N. Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease. Hepatology 2010; 51: 111-120 [PMID: 19885878 DOI: 10.1002/hep.23271]
11. Puri P, Wiest MM, Cheung O, Mirshahi F, Sargeant C, Min HK, Contos MJ, Sterling RK, Fuchs M, Zhou H, Watkins SM, Sanyal AJ. The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology 2009; 50: 1827-1838 [PMID: 19937697 DOI: 10.1002/hep.23229]
12. Cordero P, Campion J, Milagro FI, Martinez JA. Transcriptomic and epigenetic changes in early liver steatosis associated to obesity: effect of dietary methyl donor supplementation. Mol Genet Metab 2013; 110: 388-395 [PMID: 24084163 DOI: 10.1016/j.ymgme.2013.08.022]
13. Sookoian S, Pirola CJ. Systems biology elucidates common pathogenic mechanisms between nonalcoholic and alcoholic-fatty liver disease. PLoS One 2013; 8: e58895 [PMID: 23516571 DOI: 10.1371/journal.pone.0058895]
14. Li YY. Genetic and epigenetic variants influencing the development of nonalcoholic fatty liver disease. World J Gastroenterol 2012; 18: 6546-6551 [PMID: 23236228 DOI: 10.3748/wjg.v18.i45.6546]
15. Pirola CJ, Gianotti TF, Burgueño AL, Rey-Funes M, Loidl CF, Mallardi P, Martino JS, Castaño GO, Sookoian S. Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease. Gut 2013; 62: 1356-1363 [PMID: 22879518 DOI: 10.1136/gutjnl-2012-302962]
16. Sanal MG. The blind men 'see' the elephant-the many faces of fatty liver disease. World J Gastroenterol 2008; 14: 831-844 [PMID: 18240340]
17. Trovato GM. Behavior, nutrition and lifestyle in a comprehensive health and disease paradigm: skills and knowledge for a predictive, preventive and personalized medicine. EPMA J 2012; 3: 8 [PMID: 22738244 DOI: 10.1007/s13167-012-0141-2]
18. Tan HH, Fiel MI, Sun Q, Guo J, Gordon RE, Chen LC, Friedman SL, Odin JA, Allina J. Kupffer cell activation by ambient air particulate matter exposure may exacerbate non-alcoholic fatty liver disease. J Immunotoxicol 2009; 6: 266-275 [PMID: 19908945 DOI: 10.1080/15476910903241704]
19. Dhurandhar NV, Geurts L, Atkinson RL, Casteilla L, Clement K, Gerard P, Vijay-Kumar M, Nam JH, Nieuwdorp M, Trovato G, Sørensen TI, Vidal-Puig A, Cani PD. Harnessing the beneficial properties of adipogenic microbes for improving human health. Obes Rev 2013; Epub ahead of print [PMID: 23663746 DOI: 10.1111/obr.12045]
20. Trovato GM, Catalano D, Pennisi A, Trovato FM, Pace P, Martines GF, Pirri C. NAFLD (Non-Alcoholic-Fatty-Liver-Disease) reversal by a comprehensive nutritional-physical exercise intervention. FASEB J 2012; 26: 819
21. Allison DB, Downey M, Atkinson RL, Billington CJ, Bray GA, Eckel RH, Finkelstein EA, Jensen MD, Tremblay A. Obesity as a disease: a white paper on evidence and arguments commissioned by the Council of the Obesity Society. Obesity (Silver Spring) 2008; 16: 1161-1177 [PMID: 18464753 DOI: 10.1038/oby.2008.231]
22. Catalano D, Trovato GM, Martines GF, Randazzo M, Tonzuso A. Bright liver, body composition and insulin resistance changes with nutritional intervention: a follow-up study. Liver Int 2008; 28: 1280-1287 [PMID: 18435716 DOI: 10.1111/j.1478-3231.2008.01742.x]
23. Trovato GM, Catalano D, Martines GF, Pirri C, Trovato FM. Western dietary pattern and sedentary life: independent effects of diet and physical exercise intensity on NAFLD. Am J Gastroenterol 2013; 108: 1932-1933 [PMID: 24300872 DOI: 10.1038/ajg.2013.356]
24. Trovato GM, Martines GF, Trovato FM, Catalano D. Re: "Relation of the traditional Mediterranean diet to cerebrovascular disease in a Mediterranean population". Am J Epidemiol 2013; 178: 661 [PMID: 23788673 DOI: 10.1093/aje/kwt125]
25. Catalano D, Trovato GM, Pace P, Martines GF, Trovato FM. Mediterranean diet and physical activity: an intervention study. Does olive oil exercise the body through the mind? Int J Cardiol 2013; 168: 4408-4409 [PMID: 23714600 DOI: 10.1016/j.ijcard.2013.05.034]
26. Trovato GM, Pace P, Martines GF, Trovato FM, Pirri C, Catalano D. Stress, abdominal obesity and intrarenal resistive index in essential hypertension. Clin Ter 2012; 163: 299-305 [PMID: 23007813]
27. Trovato GM, Pace P, Cangemi E, Martines GF, Trovato FM, Catalano D. Gender, lifestyles, illness perception and stress in stable atrial fibrillation. Clin Ter 2012; 163: 281-286 [PMID: 23007810]
28. Trovato GM, Martines GF, Trovato FM, Pirri C, Pace P, Catalano D. Renal resistive index and parathyroid hormone relationship with renal function in nondiabetic patients. Endocr Res 2012; 37: 47-58 [PMID: 22007967 DOI: 10.3109/07435800.2011.625513]
29. Catalano D, Trovato GM, Martines GF, Pirri C, Trovato FM. Renal function and severity of bright liver. Relationship with insulin resistance, intrarenal resistive index, and glomerular filtration rate. Hepatol Int 2011; 5: 822-829 [PMID: 21484130 DOI: 10.1007/s12072-011-9254-2]
30. Trovato GM, Pirri C, Martines GF, Tonzuso A, Trovato F, Catalano D. Lifestyle interventions, insulin resistance, and renal artery stiffness in essential hypertension. Clin Exp Hypertens 2010; 32: 262-269 [PMID: 20662726 DOI: 10.3109/10641960903265204]
31. Dhurandhar NV, Kulkarni P, Ajinkya SM, Sherikar A. Effect of adenovirus infection on adiposity in chicken. Vet Microbiol 1992; 31: 101-107 [PMID: 1320784]
32. Dhurandhar NV, Israel BA, Kolesar JM, Mayhew GF, Cook ME, Atkinson RL. Increased adiposity in animals due to a human virus. Int J Obes Relat Metab Disord 2000; 24: 989-996 [PMID: 10951537]
33. Vangipuram SD, Sheele J, Atkinson RL, Holland TC, Dhurandhar NV. A human adenovirus enhances preadipocyte differentiation. Obes Res 2004; 12: 770-777 [PMID: 15166297]
34. Atkinson RL, Dhurandhar NV, Allison DB, Bowen RL, Israel BA, Albu JB, Augustus AS. Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. Int J Obes (Lond) 2005; 29: 281-286 [PMID: 15611785]
35. Salehian B, Forman SJ, Kandeel FR, Bruner DE, He J, Atkinson RL. Adenovirus 36 DNA in adipose tissue of patient with unusual visceral obesity. Emerg Infect Dis 2010; 16: 850-852 [PMID: 20409382 DOI: 10.3201/eid1605.091271]
36. Trovato GM, Castro A, Tonzuso A, Garozzo A, Martines GF, Pirri C, Trovato F, Catalano D. Human obesity relationship with Ad36 adenovirus and insulin resistance. Int J Obes (Lond) 2009; 33: 1402-1409 [PMID: 19786969 DOI: 10.1038/ijo.2009.196]
37. Mast TC, Kierstead L, Gupta SB, Nikas AA, Kallas EG, Novitsky V, Mbewe B, Pitisuttithum P, Schechter M, Vardas E, Wolfe ND, Aste-Amezaga M, Casimiro DR, Coplan P, Straus WL, Shiver JW. International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials. Vaccine 2010; 28: 950-957 [PMID: 19925902 DOI: 10.1016/j.vaccine.2009.10.145]
38. Mathiesen UL, Franzén LE, Aselius H, Resjö M, Jacobsson L, Foberg U, Frydén A, Bodemar G. Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. Dig Liver Dis 2002; 34: 516-522 [PMID: 12236486]
39. Caturelli E, Pompili M, Bartolucci F, Siena DA, Sperandeo M, Andriulli A, Bisceglia M. Hemangioma-like lesions in chronic liver disease: diagnostic evaluation in patients. Radiology 2001; 220: 337-342 [PMID: 11477234]
40. Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, Grimaldi A, Capron F, Poynard T; LIDO Study Group. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005; 128: 1898-1906 [PMID: 15940625]
41. Trovato GM, Martines GF, Garozzo A, Tonzuso A, Timpanaro R, Pirri C, Trovato FM, Catalano D. Ad36 adipogenic adenovirus in human non-alcoholic fatty liver disease. Liver Int 2010; 30: 184-190 [PMID: 19840251 DOI: 10.1111/j.1478-3231.2009.02127.x]
42. Atkinson RL. Human adenovirus-36 and non-alcoholic fatty liver disease. Liver Int 2010; 30: 164-165 [PMID: 20456035 DOI: 10.1111/j.1478-3231.2009.02190.x]
43. Dhurandhar EJ, Krishnapuram R, Hegde V, Dubuisson O, Tao R, Dong XC, Ye J, Dhurandhar NV. E4orf1 improves lipid and glucose metabolism in hepatocytes: a template to improve steatosis & hyperglycemia. PLoS One 2012; 7: e47813 [PMID: 23110104 DOI: 10.1371/journal.pone.0047813]
44. Lin WY, Dubuisson O, Rubicz R, Liu N, Allison DB, Curran JE, Comuzzie AG, Blangero J, Leach CT, Göring H, Dhurandhar NV. Long-term changes in adiposity and glycemic control are associated with past adenovirus infection. Diabetes Care 2013; 36: 701-707 [PMID: 23160725 DOI: 10.2337/dc12-1089]
45. Trovato GM, Catalano D, Martines GF, Trovato FM. Comment on: Lin et al. Long-term changes in adiposity and glycemic control are associated with past adenovirus infection. Diabetes Care 2013; 36: 701-707. Diabetes Care 2013; 36: e184 [PMID: 24065857 DOI: 10.2337/dc13-0671]
46. Trovato GM, Martines GF, Pirri C, Trovato FM, Castro A, Garozzo A, Catalano D. Obesity-independent association of human adenovirus Ad37 seropositivity with nonalcoholic fatty liver disease. J Clin Gastroenterol 2012; 46: e46-e54 [PMID: 22476041 DOI: 10.1097/MCG.0b013e31824b225c]
47. Trovato GM, Catalano D, Martines GF, Trovato FM, Garozzo A, Pirri C, Tonzuso A. Compound Seropositivity of neutralizing antibodies against Adipogenic Adenoviruses (ADV36 and ADV 37): no additive effect on overweight-obesity and on Insulin Resistance (IRHOMA). The microbiome across the obesity and into the liver. FASEB J 2013; 27: 1056
48. Trovato GM, Martines GF, Trovato FM, Pirri C, Pace P, Garozzo A, Castro A, Catalano D. Adenovirus-36 seropositivity enhances effects of nutritional intervention on obesity, bright liver, and insulin resistance. Dig Dis Sci 2012; 57: 535-544 [PMID: 21953137 DOI: 10.1007/s10620-011-1903-8]
49. von Scholten BJ, Andresen EN, Sørensen TI, Jess T. Aetiological factors behind adipose tissue inflammation: an unexplored research area. Public Health Nutr 2013; 16: 27-35 [PMID: 22464010 DOI: 10.1017/S1368980012000894]
50. Rathod M, Vangipuram SD, Krishnan B, Heydari AR, Holland TC, Dhurandhar NV. Viral mRNA expression but not DNA replication is required for lipogenic effect of human adenovirus Ad-36 in preadipocytes. Int J Obes (Lond) 2007; 31: 78-86 [PMID: 16652125]
51. Vangipuram SD, Yu M, Tian J, Stanhope KL, Pasarica M, Havel PJ, Heydari AR, Dhurandhar NV. Adipogenic human adenovirus-36 reduces leptin expression and secretion and increases glucose uptake by fat cells. Int J Obes (Lond) 2007; 31: 87-96 [PMID: 16703005]
52. Pasarica M, Mashtalir N, McAllister EJ, Kilroy GE, Koska J, Permana P, de Courten B, Yu M, Ravussin E, Gimble JM, Dhurandhar NV. Adipogenic human adenovirus Ad-36 induces commitment, differentiation, and lipid accumulation in human adipose-derived stem cells. Stem Cells 2008; 26: 969-978 [PMID: 18203674 DOI: 10.1634/stemcells.2007-0868]
53. Rathod MA, Rogers PM, Vangipuram SD, McAllister EJ, Dhurandhar NV. Adipogenic cascade can be induced without adipogenic media by a human adenovirus. Obesity (Silver Spring) 2009; 17: 657-664 [PMID: 19165154 DOI: 10.1038/oby.2008.630]
54. Krishnapuram R, Dhurandhar EJ, Dubuisson O, Kirk-Ballard H, Bajpeyi S, Butte N, Sothern MS, Larsen-Meyer E, Chalew S, Bennett B, Gupta AK, Greenway FL, Johnson W, Brashear M, Reinhart G, Rankinen T, Bouchard C, Cefalu WT, Ye J, Javier R, Zuberi A, Dhurandhar NV. Template to improve glycemic control without reducing adiposity or dietary fat. Am J Physiol Endocrinol Metab 2011; 300: E779-E789 [PMID: 21266671 DOI: 10.1152/ajpendo.00703.2010]
55. Na HN, Nam JH. Adenovirus 36 as an obesity agent maintains the obesity state by increasing MCP-1 and inducing inflammation. J Infect Dis 2012; 205: 914-922 [PMID: 22275403 DOI: 10.1093/infdis/jir864]
56. Krishnapuram R, Dhurandhar EJ, Dubuisson O, Hegde V, Dhurandhar NV. Doxycycline-regulated 3T3-L1 preadipocyte cell line with inducible, stable expression of adenoviral E4orf1 gene: a cell model to study insulin-independent glucose disposal. PLoS One 2013; 8: e60651 [PMID: 23544159 DOI: 10.1371/journal.pone.0060651]
57. Dhurandhar NV. Insulin sparing action of adenovirus 36 and its E4orf1 protein. J Diabetes Complications 2013; 27: 191-199 [PMID: 23246247 DOI: 10.1016/j.jdiacomp.2012.09.006]
58. Dhurandhar EJ, Dubuisson O, Mashtalir N, Krishnapuram R, Hegde V, Dhurandhar NV. E4orf1: a novel ligand that improves glucose disposal in cell culture. PLoS One 2011; 6: e23394 [PMID: 21886789 DOI: 10.1371/journal.pone.0023394]
59. Greenberg JA . The obesity paradox in the US population. Am J Clin Nutr 2013; 97: 1195-1200 [PMID: 23636238 DOI: 10.3945/ajcn.112.045815]
60. Trovato GM, Catalano D, Trovato FM. The challenge of obesity: can we look to the moon instead of the finger? J Am Coll Cardiol 2013; 62: 1036 [PMID: 23643506 DOI: 10.1016/j.jacc.2013.03.066]
61. Fezeu L, Julia C, Henegar A, Bitu J, Hu FB, Grobbee DE, Kengne AP, Hercberg S, Czernichow S. Obesity is associated with higher risk of intensive care unit admission and death in influenza A (H1N1) patients: a systematic review and meta-analysis. Obes Rev 2011; 12: 653-659 [PMID: 21457180 DOI: 10.1111/j.1467-789X.2011.00864.x]